Tirofiban versus abciximab and heparin versus bivalirudin in coronary artery disease patients undergoing PCI and stent placement and also receiving clopidogrel + aspirin

Trial Profile

Tirofiban versus abciximab and heparin versus bivalirudin in coronary artery disease patients undergoing PCI and stent placement and also receiving clopidogrel + aspirin

Discontinued
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2011

At a glance

  • Drugs Abciximab (Primary) ; Bivalirudin (Primary) ; Heparin (Primary) ; Tirofiban (Primary)
  • Indications Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis
  • Focus Therapeutic Use
  • Acronyms TENACITY
  • Most Recent Events

    • 20 Jul 2011 New trial record
    • 01 Jun 2011 Results published in Catheterization and Cardiovascular Interventions.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top